Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Shareholders of Avangard Bank approved dividends for 2024
4/18/25
AVAN
Mosenergo reported for 2024 by RAS
4/18/25
MSNG
Etalon Group received Cyprus redomiciliation authorization
4/18/25
ETLN
Chizhik's opened its 2,500th store
4/18/25
X5
LSR will build premium housing on the site of the former Liviz distillery
4/18/25
LSRG
MTS started an experiment of selling cars in communication salons
4/18/25
MTSS
Element Group agreed to cooperate with ZNTC for microelectronics production
4/18/25
ELMT
Sistema reported for 2024 by IFRS
4/17/25
AFKS
TMK decided to refuse dividends for 2024
4/17/25
TRMK
NLMK reported for 2024 by IFRS
4/17/25
NLMK
«
Previous
34
35
36
37
38
39
40
41
42
43
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 